During the past decade, Elite Women's Health conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Elite Women's Health" #1 collaborator was "National Reference Laboratory for Breast Health" with 1 trials as a collaborator, "Puget Sound Institute of Pathology" with 1 trials as a collaborator, "Quest Diagnostics-Nichols Insitute" with 1 trials as a collaborator and "Sound Pathology Associates" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Elite Women's Health" are "Abnormalities." (1 trials), "Breast Neoplasms" (1 trials), "Down Syndrome (Trisomy 21)" (1 trials), "Edward's Syndrome (Trisomy 18)" (1 trials) and "Klinefelter Syndrome (47, XXY)" (1 trials). Many other conditions were trialed in "Elite Women's Health" in a lesser frequency.

Most popular intervention types in "Elite Women's Health" are "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "ForeCYTE Breast Aspirator" (1 trials). Other intervention names were less common.

The vast majority of trials in "Elite Women's Health" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Elite Women's Health". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Elite Women's Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Elite Women's Health, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".